Monoclonal antibody G250RIT

Drug Profile

Monoclonal antibody G250RIT

Alternative Names: WX-G250RIT

Latest Information Update: 20 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Centocor
  • Developer Wilex
  • Class Monoclonal antibodies; Radiopharmaceuticals; Radiosensitisers
  • Mechanism of Action Ionising radiation emitters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Renal cancer
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Biliary cancer; Renal cancer

Most Recent Events

  • 26 Jun 2003 Phase-I/II clinical trials in Biliary cancer in Netherlands (IV)
  • 22 Apr 2002 Phase-II clinical trials in Renal cancer in Germany (IV)
  • 22 Apr 2002 Preclinical trials in Biliary cancer in Germany (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top